학술논문
Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study
Document Type
Article
Author
Miller, Jutta L.; Eshach Adiv, Orly; Bilgic Eltan, Sevgi; Yorgun Altunbas, Melek; Magliocco, Mary; Matthews, Helen; Marciano, Beatriz E.; Chatchatee, Pantipa; Trbovic, Caryn F.; Burczynski, Michael E.; Chaudhari, Umesh; Usta, Yusuf; Altuntaş, Cansu; Yavuz, Sibel; Baştürk, Ahmet; Demirbaş Ar, Fatma; Topal, Erdem; Kalaycı, Ayhan Gazi; Weerapakorn, Wanlapa; Calabi Martínez, Ana Andrea; Bottero, Adriana; Ozen, Ahmet; Chongsrisawat, Voranush; Sefer, Asena Pinar; Kolukisa, Burcu; Jalbert, Jessica J; Meagher, Karoline A; Brackin, Taylor; Feldman, Hagit Baris; Baris, Safa; Karakoc-Aydiner, Elif; Ergelen, Rabia; Fuss, Ivan J; Moorman, Heather; Suratannon, Narissara; Suphapeetiporn, Kanya; Perlee, Lorah; Harari, Olivier A ; Yancopoulos, George D; Lenardo, Michael J
Source
In The Lancet 17-23 February 2024 403(10427):645-656
Subject
Language
ISSN
0140-6736